AI Tool Successfully Identifies Brain Microbleeds in Clinical Trial
A newly evaluated deep learning software has demonstrated high sensitivity and a low false-positive rate in detecting cerebral microbleeds on MRI scans, according to a recent clinical trial.
Key points
- Automated AI software evaluated for cerebral microbleed detection
- Clinical trial tested model on 457 MRI examinations
- Software achieved 88.35% sensitivity with 0.95 false positives per patient
Researchers evaluating the Neurophet SCALE MRI software have found that the deep learning-based tool successfully identifies cerebral microbleeds—small brain lesions that serve as important biomarkers for cognitive decline and cerebrovascular disease. Published in Nature Health Sciences, the retrospective single-center clinical trial tested the automated model on 457 MRI examinations involving 456 participants with a total of 515 microbleed lesions.
The software utilizes a two-stage deep learning pipeline, first generating lesion candidates using a multiscale backbone and convolutional Long Short-Term Memory, and subsequently reducing false positives through a classifier and brain tissue segmentation. According to the findings, the device exceeded its primary endpoints by achieving a lesion-wise sensitivity of 88.35 percent alongside a low false-positive rate of 0.95 per patient. Furthermore, the patient-wise sensitivity reached a perfect 1.0, with a specificity of 0.86.
While the study demonstrates promising diagnostic metrics, the retrospective and single-center design means that further validation by expert readers across broader populations is necessary to confirm its broader clinical utility. Several authors of the study are current or former employees of Neurophet Inc., the manufacturer of the software, and the trial was sponsored by the company.
What to know: Automated artificial intelligence tools may soon assist radiologists in identifying critical neurological markers like cerebral microbleeds, though patients should always consult qualified medical professionals regarding personal health decisions and neurological care.
Source Nature Health Sciences — nature.com/articles/s41598-026-77551-0 ↗
Read next
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…
🏃FitnessExpert Advice on Hydration Gear Sparks Debate Among Recreational Runners
Olympic medalist Josh Kerr recently suggested that runners may not require hydration packs for distances under 12 miles, igniting a broader conversation about gear necess…
🏃FitnessA Structured Approach to Beginning a Strength and Cardio Routine
A new four-week training program offers beginners a guided path to incorporating strength training and cardiovascular exercise into their daily lives.
🏥Public HealthRecall Issued for Generic Propranolol Over Potential Metal Contamination
Breckenridge Pharmaceutical has initiated a voluntary recall of one lot of generic propranolol capsules due to the potential presence of metal fragments.
🥗NutritionUnderstanding Food Science: Why Some Leftovers Freeze Better Than Others
Freezing leftovers is an effective way to minimize food waste, though the success of the process depends on the cellular structure and composition of the food being store…